Dragon Pharma Tesamorelin is supplied as a lyophilized powder in a 2 mL vial and contains the growth hormone-releasing hormone analogue tesamorelin at a labeled strength of 5 mg. Product specifications, storage information, and available payment options are provided below.
5 mg Peptide Strength
Each vial contains a labeled strength of 5 mg of tesamorelin.
Lyophilized Powder Form
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
2 mL Vial
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
GHRH Analogue
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone that has been investigated in research for its effects on growth hormone secretion.
Product Specifications
Product name
Tesamorelin 5 mg
Active substance
Tesamorelin
Labeled strength
5 mg/vial
Container
2 mL vial
Total labeled content
5 mg per vial
Product form
Lyophilized powder
Manufacturer
Dragon Pharma
Related Peptide Options
Other peptide options from the same product line include Sermorelin 5 mg, another GHRH analogue, and Ipamorelin 5 mg, a growth hormone-releasing peptide with a different mechanism of action. Tesamorelin has been investigated for its specific GHRH receptor activity in research settings.
Science & Research
Understanding Tesamorelin
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that acts on the GHRH receptor to stimulate growth hormone release. This section provides a brief overview of what is known about this peptide from research literature.
1
GHRH Analogue
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone. It acts on the GHRH receptor to stimulate growth hormone secretion from the pituitary gland.
2
Research Applications
Preclinical and clinical research has investigated tesamorelin for its effects on growth hormone secretion and related physiological processes. It has been studied for its interactions with the growth hormone axis.
3
Mechanism of Action
Tesamorelin binds to the GHRH receptor on pituitary cells, triggering a signaling cascade that leads to the release of growth hormone. Its mechanism is distinct from that of GHRPs such as ipamorelin.
Peptide Reconstitution and Use
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Research References
Peer-reviewed research on tesamorelin is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Peptide research compounds such as tesamorelin have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of the growth hormone axis and does not constitute medical advice.
Limited Clinical Data
Tesamorelin has limited safety data outside of approved clinical use contexts. The available information comes primarily from research settings.
Growth Hormone Effects
Peptides that stimulate growth hormone release have the potential to affect glucose metabolism, insulin sensitivity and fluid balance. These effects are not fully characterized for tesamorelin.
Injection-Related Risks
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
Hormonal Interactions
Compounds that affect the growth hormone axis may interact with other hormonal systems, including thyroid and adrenal function. The potential significance of these interactions is not fully understood.
Contraindications
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
Limited Research
The long-term effects and safety profile of tesamorelin have not been established in any population. Research on this peptide is ongoing.
Conditions That Require Medical Review
Medical advice is particularly important for individuals with diabetes or glucose metabolism disorders, cardiovascular disease, cancer or a history of cancer, pituitary disorders, or those taking medications that affect hormone levels. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Tested Sport
Growth hormone-releasing peptides and analogues, including tesamorelin, are prohibited under anti-doping rules in tested sport unless an applicable therapeutic-use exemption has been granted.
Quick answers about Tesamorelin 5 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma Tesamorelin 5 mg?
Dragon Pharma Tesamorelin 5 mg is a lyophilized peptide product containing 5 mg of the GHRH analogue tesamorelin per vial. It is supplied in a 2 mL vial for research purposes.
What is tesamorelin?
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that acts on the GHRH receptor to stimulate growth hormone release from the pituitary gland.
How much peptide is in each vial?
Each vial contains a labeled strength of 5 mg of Tesamorelin.
How is the product supplied?
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
How should Tesamorelin be stored?
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Does Tesamorelin require refrigeration?
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
How long does Tesamorelin delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Tesamorelin with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Tesamorelin 5 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is Tesamorelin permitted in tested sport?
Growth hormone-releasing peptides and analogues, including tesamorelin, are prohibited under anti-doping rules in tested sport unless an applicable therapeutic-use exemption has been granted. Current requirements should be checked against the relevant anti-doping rules before competition.
Where can I find more information on Tesamorelin?
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
